靶点针对疾病信息21(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T18477
TARGNAME
Heat shock protein 90 alpha (HSP90A)
INDICATI
Approved Acute upper respiratory infection [ICD-11: CA07]
INDICATI
Approved Vasomotor/allergic rhinitis [ICD-11: CA08]
INDICATI
Phase 2 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 2 Multiple myeloma [ICD-11: 2A83]
INDICATI
Phase 1/2 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 1/2 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 1/2 Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Phase 1/2 Stomach cancer [ICD-11: 2B72]
INDICATI
Phase 1 Encephalopathy [ICD-11: 8E47]
INDICATI
Phase 1 Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Phase 1 Neuropathy [ICD-11: 8C0Z]
INDICATI
Discontinued in Phase 3 Diabetes mellitus [ICD-11: 5A10]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3